MIMEDX GROUP, INC. (MDXG) › Cash & EquivalentsMIMEDX GROUP, INC. (MDXG) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2009-12-31: $2.65M2010-12-31: $1.34M2011-12-31: $4.11M2012-12-31: $6.75M2013-12-31: $44.08M2014-12-31: $46.58M2015-12-31: $26.30M2016-12-31: $30.32M2017-12-31: $27.48M2018-12-31: $45.12M2019-12-31: $69.07M2020-12-31: $95.81M2021-12-31: $87.08M2022-12-31: $65.95M2023-12-31: $82.00M2024-12-31: $104.42M2025-12-31: $166.12M$166.12M2009-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$166.12M+59.1%2026-02-25Balance as of period end2024-12-31$104.42M+27.3%2026-02-25Balance as of period end2023-12-31$82.00M+24.3%2025-02-26Balance as of period end2022-12-31$65.95M-24.3%2024-02-28Balance as of period end2021-12-31$87.08M-9.1%2023-02-28Balance as of period end2020-12-31$95.81M+38.7%2022-02-28Balance as of period end2019-12-31$69.07M+53.1%2021-03-08Balance as of period end2018-12-31$45.12M+64.2%2020-07-06Balance as of period end2017-12-31$27.48M-9.4%2020-03-17Balance as of period end2016-12-31$30.32M+15.3%2020-03-17Balance as of period end2015-12-31$26.30M-43.5%2020-03-17Balance as of period end2014-12-31$46.58M+5.7%2017-03-01Balance as of period end2013-12-31$44.08M+552.6%2017-03-01Balance as of period end2012-12-31$6.75M+64.2%2017-02-22Balance as of period end2011-12-31$4.11M+206.7%2015-03-13Balance as of period end2010-12-31$1.34M-49.5%2014-03-04Balance as of period end2009-12-31$2.65M—2012-03-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)